Arecor Therapeutics Balance Sheet Health
Financial Health criteria checks 4/6
Arecor Therapeutics has a total shareholder equity of £13.2M and total debt of £0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are £20.1M and £6.9M respectively.
Key information
0%
Debt to equity ratio
UK£0
Debt
Interest coverage ratio | n/a |
Cash | UK£8.23m |
Equity | UK£13.21m |
Total liabilities | UK£6.92m |
Total assets | UK£20.13m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: AREC's short term assets (£16.1M) exceed its short term liabilities (£6.4M).
Long Term Liabilities: AREC's short term assets (£16.1M) exceed its long term liabilities (£547.0K).
Debt to Equity History and Analysis
Debt Level: AREC is debt free.
Reducing Debt: AREC has no debt compared to 5 years ago when its debt to equity ratio was 33.6%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if AREC has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if AREC has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.